Beam Therapeutics
Price & Volume
Stats
See more52W Range | $13.52-$36.44 |
Market Cap | $2.9B |
Shares Short | 20M |
Financials
See moreRevenue (12 Mos) | $139.7M |
Revenue Growth (YoY) | 279.5% |
Gross Profit (12 Mos) | $139.7M |
Diluted EPS | -$4.41 |
News
See moreYahoo Finance • 7 days ago
Genomics Stocks That Deserve a Place in Your Portfolio in 2026
Yahoo Finance • 7 days ago
Walmart downgraded, Etsy upgraded: Wall Street's top analyst calls
Yahoo Finance • 11 days ago
Here is Why Beam Therapeutics (BEAM) Appears so Attractive
Yahoo Finance • 12 days ago
H.C. Wainwright Reiterated Buy on Beam Therapeutics (BEAM) After BEAM-302 FDA Expedited Approval
About
CEO | Mr. John M. Evans M.B.A. |
Address | 238 Main Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 510 |
